Beranda › Kanker Laring › Montana › Billings
Uji klinis Kanker Laring di Billings, MT
4 studi untuk Kanker Laring mencari peserta di lokasi sekitar Billings (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
- Billings Clinic Cancer Center, Billings
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Menerima pesertaFase 2
- Billings Clinic Cancer Center, Billings
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Billings
Uji klinis Kanker Laring di kota lain
- Atlanta, GA8 studi
- Chicago, IL8 studi
- Milwaukee, WI8 studi
- Kansas City, MO7 studi
- Portland, OR7 studi
- St. Louis, MO7 studi
- Baltimore, MD6 studi
- Cincinnati, OH6 studi
- Edison, NJ6 studi
- Richmond, VA6 studi
- Durham, NC6 studi
- Pittsburgh, PA6 studi
Studi lain di Billings
- Kanker Paru Non-Sel Kecil17 studi
- Kanker Prostat15 studi
- Kanker Paru13 studi
- Kanker Payudara10 studi
- Kanker Ovarium9 studi
- Melanoma7 studi
- Leukemia Limfositik Kronis7 studi
- Leukemia Mieloid Akut7 studi
- Kanker Kandung Kemih6 studi
- Kanker Kolon6 studi
- Kanker Kolorektal6 studi
- Kanker Rektum5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.